{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00429",
      "entity_text" : "elderly.10",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:43815",
      "entity_text" : "paroxetine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Some case reports indicated that the co-medication of metoprolol and paroxetine / fluoxetine produces bradycardia and atrioventricular block in elderly.10, 16, 17 However, another observational study found that the risk of bradycardia in the older population with the interacting combination is not different from those without the combination.7 Therefore, the objective of this study was to investigate the clinical impact of such DDI by analyzing the effect of paroxetine or fluoxetine co-prescription to the existing treatment with metoprolol on the metoprolol discontinuation rate or defined daily dose (DDD) among elderly.",
  "reading_complete" : "2020-08-05T20:59:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T20:58:05Z",
  "trigger" : "produces",
  "evidence" : [ "paroxetine/fluoxetine produces bradycardia and atrioventricular block in elderly.10" ],
  "pmc_id" : "6001522",
  "score" : 0
}